A mathematical model for developing hepatitis E virus infection in human population

Cover Page


Cite item

Full Text

Abstract

Hepatitis E is an acute viral infectious disease transmitted by fecal-oral route mainly through fecally contaminated drinking water, with cyclic outbreaks and frequent development of acute hepatic encephalopathy in pregnant women. Hepatitis E epidemic outbreaks occur in Central Asia, Africa and Latin America, whereasChina,India,Turkmenistan,Kazakhstan,Tajikistan,Uzbekistan,Kyrgyzstan,Bolivia,Mexico, andTaiwanrepresent endemic geographic regions. Hepatitis E in the structure of acute viral hepatitis morbidity during outbreaks ranges from 64.7% to 80%, whereas sporadic morbidity may be up to 10 to 18.8%. In contrast, percentage of hepatitis E in acute viral hepatitis varies from 0.5% to 12.6% in European countries and some territories of theRussian Federation. The latent active virus circulation was confirmed in various regions of theRussian Federation. All introduced cases were related to recent traveling to the regions with high incidence of hepatitis E, which course clinically did not differ from standard hepatitis E infection, but no cases of infection were recorded after exposure. Lack of contact transmission in this case was associated with low virus survival in environment. Patients with any clinical form including anicteric serve as a source of infection. An increased risk of hepatitis E infection is typical for livestock workers dealing with pigs, employe es of meat processing plants engaged in primary meat carcass processing and working at slaughterhouse. According to the World Health Organization, 20 million cases of hepatitis E virus infection are recorded annually, among which 3 million cases account for acute hepatitis E and related 70 000 lethal outcomes. Chronic liver disorders comprising up to 70% followed by death of pregnant women (40%) as well as acute liver and kidney failure reaching as low as 4% result in lethal outcome in hepatitis E patients. Creating a mathematical model for development of hepatitis E infection could allow to predict changes in its morbidity rate at controlled area. Here, for the first time we propose a mathematical model for developing hepatitis E in human population based on disease course, which may potentially predict an incidence rate for the most dangerous icteric hepatitis E as well as assess amount of individuals susceptible to it at morbidity rise in the geographic region. 

About the authors

N. A. Kontarov

I.M. Sechenov First Moscow State Medical University;
I.I. Mechnikov Research Institute of Vaccines and Sera

Author for correspondence.
Email: kontarova@mail.ru

PhD (Biology), Аssociate Professor, Department of Medical and Biological Physics, I.M. Sechenov First Moscow State Medical University; Senior Researcher, Laboratory of Childhood Viral Infections, I.I. Mechnikov Research Institute of Vaccines and Sera

Contacts: Nikolay A. Kontarov 105064, Russia, Moscow, Small Kazenny Lane, 5a, I.I. Mechnikov Research Institute of Vaccines and Sera. Phone: +7 (495) 674-01-99

Russian Federation

N. V. Yuminova

I.I. Mechnikov Research Institute of Vaccines and Sera

Email: yuminova@mail.ru
PhD, MD (Biology), Professor, Deputy Director for Science, Head of the Laboratory of Childhood Viral Infections Russian Federation

G. I. Alatortseva

I.I. Mechnikov Research Institute of Vaccines and Sera

Email: alatortseva@gmail.com
PhD (Biology), Head of the Laboratory of Viral Genome Cloning ions Russian Federation

L. N. Lukhverchik

I.I. Mechnikov Research Institute of Vaccines and Sera

Email: lexx294@yandex.by
PhD (Biology), Leading Researcher, Laboratory of Viral Genome Cloning an> Russian Federation

Z. Sh. Nurmatov

SPS “Preventive Medicine”

Email: z.nurmatov@mail.ru

PhD (Medicine), Head of the Republican Scientific and Practical Center on Surveillance for Viral Infections SPS “Preventive Medicine”

Bishkek

Kyrgyzstan

I. V. Pogarskyia

I.I. Mechnikov Research Institute of Vaccines and Sera

Email: kozyr.irina@inbox.ru
PhD (Biology), Senior Researcher, Laboratory of Childhood Viral Infections Russian Federation

References

  1. Khuroo M.S., Kamili S., Jameel S. Vertical transmission of hepatitis E virus. Lancet, 1995, vol. 345, pp. 1025–1026.
  2. Khuroo M.S., Kamili S., Khuroo N.S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J. Viral Hep., 2009, vol. 16, pp. 519–523. doi: 10.1111/j.1365-2893.2009.01101.x
  3. Khuroo M.S., Khuroo M.S., Khuro N.S. Hepatitis E: discovery, global impact, control and cure. World J. Gastroenterol., 2016, vol. 22, no. 31, pp. 7030–7045. doi: 10.3748/wjg.v22.i31.7030
  4. Singh S., Mohanty A., Joshi Y.K., Deka D., Mohanty S., Panda S.K. Mother-to-child transmission of hepatitis E virus infection. Indian J. Pediatr., 2003, vol. 70, pp. 37–39.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Kontarov N.A., Yuminova N.V., Alatortseva G.I., Lukhverchik L.N., Nurmatov Z.S., Pogarskyia I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies